Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice

Autor: P.M. Cogswell, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.R. Jack, T.Y. Poussaint, C.A. Raji, V.K. Ramanan, C.T. Whitlow

Publikováno v: American Journal of Neuroradiology, 43(9), E19-E35. American Society of Neuroradiology
Cogswell, P M, Barakos, J A, Barkhof, F, Benzinger, T S, Jack, C R, Poussaint, T Y, Raji, C A, Ramanan, V K & Whitlow, C T 2022, ' Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics : Detection and Reporting Recommendations for Clinical Practice ', American Journal of Neuroradiology, vol. 43, no. 9, pp. E19-E35 . https://doi.org/10.3174/ajnr.A7586

SUMMARY: Monoclonal antibodies are emerging disease-modifying therapies for Alzheimer disease that require brain MR imaging for eligibility assessment as well as for monitoring for amyloid-related imaging abnormalities. Amyloid-related imaging abnorm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88785650bfa25dd8f2ba256c910f353
https://doi.org/10.3174/ajnr.a7586

Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study.

Autor: Kodishala C; C. Kodishala, MBBS, DM, V.L. Kronzer, MD, MSCI, J.M. Davis III, MD, Division of Rheumatology, Mayo Clinic., Hulshizer CA; C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic., Kronzer VL; C. Kodishala, MBBS, DM, V.L. Kronzer, MD, MSCI, J.M. Davis III, MD, Division of Rheumatology, Mayo Clinic., Davis JM 3rd; C. Kodishala, MBBS, DM, V.L. Kronzer, MD, MSCI, J.M. Davis III, MD, Division of Rheumatology, Mayo Clinic., Ramanan VK; V.K. Ramanan, MD, PhD, Department of Neurology, Mayo Clinic., Vassilaki M; M. Vassilaki, MD, PhD, Department of Quantitative Health Sciences, Mayo Clinic., Mielke MM; M.M. Mielke, PhD, Department of Quantitative Health Sciences, Department of Neurology, Mayo Clinic., Crowson CS; C.S. Crowson, PhD, Division of Rheumatology, Department of Quantitative Health Sciences, Mayo Clinic., Myasoedova E; E. Myasoedova, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Myasoedova.elena@mayo.edu.

Publikováno v: The Journal of rheumatology [J Rheumatol] 2023 Jan; Vol. 50 (1), pp. 48-55. Date of Electronic Publication: 2022 Jul 15.